Acute Porphyria Drug Database

Monograph

S01GA51 - Naphazoline, Combinations
Propably not porphyrinogenic
PNP

Rationale
Probably no significant systemic exposure.
Chemical description
Eye drops with vasoconstrictive Nafazoline 5 mg/mL; adrenergic:and antihistaminic antazoline. Used in allergic conjunctivitis.

Similar drugs
Explore alternative drugs in similar therapeutic classes S01G / S01GA or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Belgium
Naphcon-A · Naphcon-A 3 mg/ml - 0.25 mg/ml collyre sol. flac. compte-gouttes
Denmark
Antistina-privin
Poland
Betadrin · Oculosan
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙